Newtyn Partners, L.P., Director Other at MERRIMACK PHARMACEUTICALS INC (MACK), bought 35,815 shares at $5.17 ($186K) on 2022-06-14, disclosed to the SEC on 2022-06-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.17 | 8,961 | $46K | 24.9% |
| 2 | $5.17 | 11,977 | $62K | 33.3% |
| 3 | $5.17 | 11,977 | $62K | 33.3% |
| 4 | $5.37 | 1,241 | $7K | 3.6% |
| 5 | $5.37 | 1,659 | $9K | 4.8% |
| Total | $5.19 avg | 35,815 |
| $186K |
| 100% |
| Filing → |
| MACK | BUY | 2022-02-01 | $116K | — | Filing → |
| MACK | BUY | 2020-11-27 | $504K | — | Filing → |